Literature DB >> 31149257

THE ROMANIAN VERSION OF THE THYROID-RELATED PATIENT-REPORTED OUTCOMES THYPRO AND THYPRO-39. TRANSLATION AND ASSESSMENT OF RELIABILITY AND CROSS-CULTURAL VALIDITY.

A E Zahan1,2, T Watt3, I Pascanu4,2, A K Rasmussen3, L Hegedüs5, S J Bonnema5, U Feldt-Rasmussen3, J B Bjorner6, V Nadasan7, A Boila1, I Merlan2, A Borda1.   

Abstract

BACKGROUND: ThyPRO is a recently developed thyroid-specific quality of life (QoL) questionnaire applicable to patients with benign thyroid disorders(BTD). The aim of the present study was to translate ThyPRO and ThyPRO-39 into Romanian, and to evaluate reliability and cross-cultural validity.
METHODS: Standard methodology for translation and linguistic validation of patient-reported outcomes (PRO) was applied. The questionnaire was completed by 130 patients with benign thyroid diseases seen at Department of Endocrinology in the Emergency County Hospital, Tîrgu Mureş, Romania, between October 2015 and March 2016. Internal reliability of the Romanian version of the ThyPRO (ThyPROro) scales was assessed for multi-item scales using Cronbach's alpha coefficient. An efficient method for testing cross-cultural validity is analysis of differential item functioning (DIF). Uniform DIF between the Romanian and the original Danish sample was investigated using ordinal logistic regression. The translation process proceeded without difficulties, and any disagreements were revised by one of the developers and the language coordinator.
RESULTS: Internal reliability for ThyPRO was satisfactory. Cronbach`s alpha coefficients for the 13 scales ranged from 0.78 to 0.93 for the ThyPROro and 0.78 to 0.87 for the ThyPROro-39. In the 85-item ThyPRO, nine instances of DIF were found. Most were minor, explaining <3% of the variation in scale score, but DIF in positively worded items were larger, with explained variance (R2's) around 10-15%.
CONCLUSION: The ThyPROro questionnaire is ready for assessment of health-related quality of life in Romanian patients with benign thyroid diseases.

Entities:  

Keywords:  Romanian versions; benign thyroid disease; quality of life; questionnaire

Year:  2018        PMID: 31149257      PMCID: PMC6516517          DOI: 10.4183/aeb.2018.192

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  31 in total

1.  Use of differential item functioning analysis to assess the equivalence of translations of a questionnaire.

Authors:  Morten Aa Petersen; Mogens Groenvold; Jakob B Bjorner; Neil Aaronson; Thierry Conroy; Ann Cull; Peter Fayers; Marianne Hjermstad; Mirjam Sprangers; Marianne Sullivan
Journal:  Qual Life Res       Date:  2003-06       Impact factor: 4.147

Review 2.  Conceptualization and measurement of health-related quality of life: comments on an evolving field.

Authors:  John E Ware
Journal:  Arch Phys Med Rehabil       Date:  2003-04       Impact factor: 3.966

3.  The use of differential item functioning analyses to identify cultural differences in responses to the EORTC QLQ-C30.

Authors:  N W Scott; P M Fayers; N K Aaronson; A Bottomley; A de Graeff; M Groenvold; M Koller; M A Petersen; M A G Sprangers
Journal:  Qual Life Res       Date:  2006-11-16       Impact factor: 4.147

4.  The Short-Form Headache Impact Test (HIT-6) was psychometrically equivalent in nine languages.

Authors:  Marie Martin; Bonnie Blaisdell; Jackie W Kwong; Jakob B Bjorner
Journal:  J Clin Epidemiol       Date:  2004-12       Impact factor: 6.437

5.  Differential item functioning and health assessment.

Authors:  Jeanne A Teresi; John A Fleishman
Journal:  Qual Life Res       Date:  2007-04-19       Impact factor: 4.147

6.  Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS).

Authors:  Bryce B Reeve; Ron D Hays; Jakob B Bjorner; Karon F Cook; Paul K Crane; Jeanne A Teresi; David Thissen; Dennis A Revicki; David J Weiss; Ronald K Hambleton; Honghu Liu; Richard Gershon; Steven P Reise; Jin-shei Lai; David Cella
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

7.  Differential item functioning analysis with ordinal logistic regression techniques. DIFdetect and difwithpar.

Authors:  Paul K Crane; Laura E Gibbons; Lance Jolley; Gerald van Belle
Journal:  Med Care       Date:  2006-11       Impact factor: 2.983

8.  IRT health outcomes data analysis project: an overview and summary.

Authors:  Karon F Cook; Cayla R Teal; Jakob B Bjorner; David Cella; Chih-Hung Chang; Paul K Crane; Laura E Gibbons; Ron D Hays; Colleen A McHorney; Katja Ocepek-Welikson; Anastasia E Raczek; Jeanne A Teresi; Bryce B Reeve
Journal:  Qual Life Res       Date:  2007-03-10       Impact factor: 4.147

9.  Health-related quality of life in patients with thyroid disorders.

Authors:  G P Bianchi; V Zaccheroni; E Solaroli; F Vescini; R Cerutti; M Zoli; G Marchesini
Journal:  Qual Life Res       Date:  2004-02       Impact factor: 4.147

Review 10.  Quality of life in patients with benign thyroid disorders. A review.

Authors:  Torquil Watt; Mogens Groenvold; Ase Krogh Rasmussen; Steen Joop Bonnema; Laszlo Hegedüs; Jakob Bue Bjorner; Ulla Feldt-Rasmussen
Journal:  Eur J Endocrinol       Date:  2006-04       Impact factor: 6.664

View more
  3 in total

Review 1.  Thyroid disease-specific quality of life questionnaires - A systematic review.

Authors:  Verena Uslar; Caroline Becker; Dirk Weyhe; Navid Tabriz
Journal:  Endocrinol Diabetes Metab       Date:  2022-07-20

2.  Psychometric properties of the thyroid-specific quality of life questionnaire ThyPRO in Singaporean patients with Graves' disease.

Authors:  Huiling Liew; Torquil Watt; Luo Nan; Alvin W K Tan; Yiong Huak Chan; Daniel Ek Kwang Chew; Rinkoo Dalan
Journal:  J Patient Rep Outcomes       Date:  2021-07-08

3.  Validity and reliability of the German version of the shortened thyroid-specific quality of life questionnaire (ThyPRO-39de).

Authors:  Navid Tabriz; Kilian Gloy; Astrid Schantzen; Dennis Fried; Dirk Weyhe; Verena Uslar
Journal:  Endocr Connect       Date:  2021-09-01       Impact factor: 3.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.